Markel Co. (NYSE:MKL) Vice Chairman Steven A. Markel sold 200 shares of the business’s stock in a transaction that occurred on Thursday, February 15th. The stock was sold at an average price of $1,125.96, for a total value of $225,192.00. Following the sale, the insider now directly owns 106,243 shares in the company, valued at approximately $119,625,368.28. The sale was disclosed in a legal filing with the SEC, which is available through this link.
Shares of Markel Co. (MKL) opened at $1,108.00 on Wednesday. Markel Co. has a 52 week low of $936.95 and a 52 week high of $1,157.30. The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 0.28. The stock has a market capitalization of $15,712.36, a P/E ratio of 1,948.38 and a beta of 0.95.
Hedge funds have recently bought and sold shares of the stock. Toronto Dominion Bank lifted its stake in Markel by 11.0% in the 2nd quarter. Toronto Dominion Bank now owns 171 shares of the insurance provider’s stock valued at $167,000 after buying an additional 17 shares in the last quarter. California Public Employees Retirement System lifted its stake in Markel by 3.4% in the 3rd quarter. California Public Employees Retirement System now owns 29,434 shares of the insurance provider’s stock valued at $31,435,000 after buying an additional 968 shares in the last quarter. State of Wisconsin Investment Board lifted its stake in Markel by 4.4% in the 3rd quarter. State of Wisconsin Investment Board now owns 12,614 shares of the insurance provider’s stock valued at $13,471,000 after buying an additional 533 shares in the last quarter. Wells Fargo & Company MN lifted its stake in Markel by 1.4% in the 3rd quarter. Wells Fargo & Company MN now owns 76,310 shares of the insurance provider’s stock valued at $81,497,000 after buying an additional 1,022 shares in the last quarter. Finally, Rhumbline Advisers lifted its stake in Markel by 4.3% in the 3rd quarter. Rhumbline Advisers now owns 16,470 shares of the insurance provider’s stock valued at $17,590,000 after buying an additional 676 shares in the last quarter. 76.65% of the stock is currently owned by hedge funds and other institutional investors.
Several equities research analysts have recently commented on the company. Zacks Investment Research raised Markel from a “hold” rating to a “buy” rating and set a $1,238.00 price target on the stock in a research note on Friday, January 12th. SunTrust Banks boosted their price target on Markel to $1,200.00 and gave the stock a “hold” rating in a research note on Thursday, February 8th. Boenning Scattergood reissued a “buy” rating on shares of Markel in a research note on Thursday, October 26th. Finally, Royal Bank of Canada reissued a “hold” rating and set a $1,200.00 price target on shares of Markel in a research note on Thursday, February 8th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $1,172.00.
ILLEGAL ACTIVITY WARNING: This piece of content was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another site, it was copied illegally and reposted in violation of US and international copyright laws. The legal version of this piece of content can be read at https://www.dispatchtribunal.com/2018/02/21/markel-co-mkl-vice-chairman-steven-a-markel-sells-200-shares-of-stock.html.
Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.
Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.